PB0776 Characterization of the Effects of Hydroxyurea and Crizanlizumab on Plasma Immunothrombosis Biomarkers in Patients with Sickle Cell DiseaseVeronica Bochenek, Kandace Gollomp, An Ngo et al.|Research and Practice in Thrombosis and Haemostasis|2023Cited by 0